Caresyntax
Caresyntax offers AI-powered software, devices, and clinical services designed to enhance surgical outcomes. With a significant global presence in operating rooms, their technology has been utilized in millions of surgeries and boasts a substantial user base of surgical professionals.
Enquyst Technologies
Enquyst Technologies is developing the next-generation biopharmaceutical manufacturing platform which aims to redesign the downstream bioprocess equipment to bring unprecedented advantages in cost, time, footprint, and speed to market at commercial scale.
Endeavor Biomedicines
Endeavor’s ENV-101 is a second-generation Hedgehog inhibitor with a highly favorable efficacy and side-effect profile compared to the molecules currently in the market. ENV-101 inhibits target pathway by ~90% at all tested doses.